COVID-19 UPDATE: Firm Operations Continue Uninterrupted. Free Virtual Consultations Available. Click Here.
ACCIDENT NEWS

Pedestrian Killed in Crash on Warner Avenue


Man Hit by 2 Cars in Fatal Fountain Valley Accident

Fountain Valley, CA (June 25, 2020) – A pedestrian was killed in a crash in Fountain Valley. The fatal accident occurred on the evening of June 25 on Warner Avenue.

A man was hit by an Acura RDX and a BMW X3 on Warner Avenue. The victim was found on the road after the crash. He was taken to a local hospital, where he later died. Both drivers stopped at the accident scene. 

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Fountain Valley

#92708


April 16, 2020

2 Injured in Crash at East Mission Road and Pamela Drive

2 Vehicles Collide in Fallbrook Accident...


March 25, 2020

Pedestrian Killed in Crash on State Route 273 Near Alexander Avenue

Victim Hit by Car in Fatal Anderson Accident...


April 15, 2020

Motorcyclist Injured in Crash on Interstate 105 Near Wilmington Avenue

Motorcycle, Tow Truck Collide in Los Angeles Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


September 21, 2020

Lawsuit: ‘Tens Of Thousands’ Of Elmiron Patients At Risk For Vision Loss

A lawsuit filed on September 8 claims that “tens of thousands” of Elmiron patients were put at risk and hurt as a result of Janssen Pharmaceuticals’ conduct.


September 21, 2020

Lawsuit Claims Gilead Made ‘Unlawful’ Payment Over Truvada Competition

A lawsuit filed on Thursday claims that Gilead made an “unlawful” payment to Cipla in exchange for Cipla’s agreement to not compete against Truvada. The complaint states the payment “likely” came in the form of a license to produce Atripla, a license to produce Hepatitis C drugs in India or both.